Epic Bio, Founded by CRISPR Pioneer, Launches to Revolutionize Genetic Medicine With Epigenetic Engineering

Submitted by admin on July 12, 2022 - 10:49am

Source:

BioSpace

News Tags:

Headline:

snippet:

$55 million Series A financing will advance the company’s robust preclinical pipeline and ongoing discovery efforts
Epic holds exclusive license to smallest known Cas protein, enabling in vivo delivery via AAV vector to wide range of target organs
Lead program in facioscapulohumeral muscular dystrophy (FSHD) on track for clinical initiation in 2023

Search form